相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hyperprogressive Disease in Patients With Urothelial Carcinoma or Renal Cell Carcinoma Treated With PD-1/PD-L1 Inhibitors
Inhwan Hwang et al.
CLINICAL GENITOURINARY CANCER (2020)
Hyperprogressive disease in advanced cancer patients treated with nivolumab: a case series study
Roberto Petrioli et al.
ANTI-CANCER DRUGS (2020)
MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma
Andrea Forschner et al.
CANCERS (2020)
Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics
Hugo Arasanz et al.
CANCERS (2020)
Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogenetics
Sadal Refae et al.
SCIENTIFIC REPORTS (2020)
Impact of pseudoprogression and treatment beyond progression on outcome in patients with non-small cell lung cancer treated with immune checkpoint inhibitors
Sang Eun Won et al.
ONCOIMMUNOLOGY (2020)
Hyperprogressive disease in early-phase immunotherapy trials: Clinical predictors and association with immune-related toxicities
Yada Kanjanapan et al.
CANCER (2019)
Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade
Giuseppe Lo Russo et al.
CLINICAL CANCER RESEARCH (2019)
Novel clinical and radiomic predictors of rapid disease progression phenotypes among lung cancer patients treated with immunotherapy: An early report
Ilke Tunali et al.
LUNG CANCER (2019)
Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentrereal- world cohort
Bernhard Scheiner et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer
C. G. Kim et al.
ANNALS OF ONCOLOGY (2019)
PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
Takahiro Kamada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Hyperprogression after immunotherapy in patients with malignant tumors of digestive system
Zhi Ji et al.
BMC CANCER (2019)
Comprehensive Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor
Youjin Kim et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Novel patterns of response under immunotherapy
E. Borcoman et al.
ANNALS OF ONCOLOGY (2019)
Predictive factors for hyperprogressive disease during nivolumab as anti-PD1 treatment in patients with advanced gastric cancer
Akinori Sasaki et al.
GASTRIC CANCER (2019)
Serological Markers Associated With Response to Immune Checkpoint Blockade in Metastatic Gastrointestinal Tract Cancer
Zhihao Lu et al.
JAMA NETWORK OPEN (2019)
Hyperprogression after immunotherapy
Waseem Abbas et al.
SOUTH ASIAN JOURNAL OF CANCER (2019)
Hyperprogressive disease during nivolumab or irinotecan treatment in patients with advanced gastric cancer
Masahiko Aoki et al.
ESMO OPEN (2019)
Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysis
Deirdre M. H. J. ten Berge et al.
ERJ OPEN RESEARCH (2019)
Hyperprogression as a distinct outcome after immunotherapy
J. Fuentes-Antras et al.
CANCER TREATMENT REVIEWS (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
L. Paz-Ares et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy
Roberto Ferrara et al.
JAMA ONCOLOGY (2018)
Hyperprogressive disease: recognizing a novel pattern to improve patient management
Stephane Champiat et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1
Stephane Champiat et al.
CLINICAL CANCER RESEARCH (2017)
Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate
Shumei Kato et al.
CLINICAL CANCER RESEARCH (2017)
Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
E. Saada-Bouzid et al.
ANNALS OF ONCOLOGY (2017)
RECIST 1.1-Update and clarification: From the RECIST committee
Lawrence H. Schwartz et al.
EUROPEAN JOURNAL OF CANCER (2016)
Systematic Review and Meta-Analysis of Studies Evaluating Diagnostic Test Accuracy: A Practical. Review for Clinical. Researchers-Part I. General, Guidance and Tips
Kyung Won Kim et al.
KOREAN JOURNAL OF RADIOLOGY (2015)
Systematic Review and Meta-Analysis of Studies Evaluating Diagnostic Test Accuracy: A Practical Review for Clinical. Researchers-Part II. Statistical. Methods of Meta-Analysis
Juneyoung Lee et al.
KOREAN JOURNAL OF RADIOLOGY (2015)
Tumour growth kinetics assessment: added value to RECIST in cancer patients treated with molecularly targeted agents
C. Le Tourneau et al.
BRITISH JOURNAL OF CANCER (2012)
Tumour growth rates and RECIST criteria in early drug development
Carlos Gomez-Roca et al.
EUROPEAN JOURNAL OF CANCER (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Conducting Meta-Analyses in R with the metafor Package
Wolfgang Viechtbauer
JOURNAL OF STATISTICAL SOFTWARE (2010)
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
David Moher et al.
INTERNATIONAL JOURNAL OF SURGERY (2010)
Utilization of the PICO framework to improve searching PubMed for clinical questions
Connie Schardt et al.
BMC MEDICAL INFORMATICS AND DECISION MAKING (2007)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
